European ADRs Move Lower in Monday Trading



Shutterstock photo

American Depositary Receipts of European stocks were trading 0.97% lower at 115.21 on the Bank of New York Mellon Europe ADR Index on Monday.

In continental Europe, the gainers were led by pharmaceutical company Oasmia Pharmaceutical ( OASM ), and software firm Talend ( TLND ), which climbed 6.6% and 4.4% respectively. They were followed by hotel booking site Trivago ( TRVG ), and biotech company Forward Pharma ( FWP ),which rose 3.9% and 2.2%.

The decliners in continental Europe were led by 3D printer company Materialise ( MTLS ), and biopharmaceutical firm DBV Technologies (DBVT), which fell 6.1% and 4.9% respectively. They were followed by consumer goods company Unilever (UN), and oil company TOTAL (TOT), which dropped 1.2% and 0.8%.

In the UK and Ireland, the gainers were led by Trinity Biotech (TRIB), and biopharmaceutical company Akari Therapeutics (AKTX), which rose 9.8% and 6.1% respectively. They were followed by mining company Randgold Resources (GOLD), and media company Pearson (PSO), which were up 3.2% and 2.3%.

The decliners in the UK and Ireland were led by specialty pharmaceutical company Midatech Pharma (MTP), and biopharmaceutical company Amarin (AMRN), which fell 11.4% and 6.4% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL), and gene therapy company Nightstar (NITE), which lost 3.7% and 1.8%.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.









Zeen is a next generation WordPress theme. It’s powerful, beautifully designed and comes with everything you need to engage your visitors and increase conversions.

Wealth Empire Newsletter
Register now for free updates and alerts

Subscribe By

Note: I have the ability to revoke this permission at any time and ask for the removal of my personal data collected by contacting us or simply clicking Unsubscribe.